cagrilintide phase 3 Three new REIMAGINE studies provide some of the strongest evidence yet for CagriSema® (cagrilintide + semaglutide) in type 2 diabetes. 🔹 REIMAGINE 1 Studied people with early type 2 diabetes CagriSema: Phase 3 Results, Dosing,

Discard opened bacteriostatic water after 28 days

FDA has removed certain bulk drug substances that were placed on the category two list and has announced it will consult the Pharmacy Compounding Advisory Committee (PCAC) for potential future inclusion of some of these peptides

We flag it only to be complete and honest about where the science actually stands, because responsible information means clearly separating what is proven from what is still being studied

Watch the July 23 PCAC meeting

Our peptides are provided as lyophilized powder and prepared to support reliable laboratory research with consistent batch quality

Third-Party Tested Batch Traceability QR Linked COA Purity Verification Third-Party Purity Testing Every batch tested by independent accredited laboratories for identity and purity verification